2023年2月1日

由於這一因素，預計北美市場將出現增長。亞太地區的增長可歸因於政府幫助孤兒疾病患者的計劃。例如，印度政府在2022年7月指示聯邦和州政府確保醫療保健計劃的發展，以治療患有孤兒疾病的患者。從2018年到2022年，銷售額顯著增長，複合年增長率為18%。在美國，患者必須為化療引起的口腔黏膜炎每循環額外支付3700美元。2021年，美國嚴重口腔黏膜炎市場預計價值7900萬美元。到2033年，全球黏液管理市場預計將達到6.699億美元。根據FMI的數據，到2033年，歐洲Mucinoses管理市場的複合年增長率將達到17.1%。FMI的一位分析師表示:“以突破性舉措為前提的前瞻性方法，將引入創新的SMA藥物，以解決罕見疾病治療中未滿足的醫療需求，預計將推動行業增長。”主要市場參與者葛蘭素史克公司、Almirall公司、默克公司、鮑什健康公司、山德士國際有限公司、輝瑞公司、阿斯利康、賽諾菲、Alencure生物技術公司和Divine實驗室是Mucinoses管理市場的主要參與者。 The following are some of the most recent developments by major manufacturers. In July 2021, AstraZeneca paid US$ 13.3 billion for acquiring Alexion Pharmaceuticals, Inc. This acquisition strengthens the corporation's rare disorder product portfolio and provides significant opportunities for expansion. In June 2022, Pfizer acquired ReViral, a privately held clinical-stage biotech company. The acquisition will demonstrate the organization's approach to progressing and innovating science through in-house competence as well as the partnership with renowned, revolutionary companies in order to deliver innovative significant developments to patient populations afflicted by serious contagious diseases such as mucinoses. View Complete Report@ https://www.futuremarketinsights.com/reports/mucinoses-management-market By Drug Class: 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario About the Healthcare Division at Future Market Insights The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts. Have a Look at Related Reports of Healthcare domain Chronic Disease Management Market Size : The global chronic disease management market garnered a value of US$ 4,315.3 Million in 2022 and is expected to accumulate a value of US$ 17,267.6 Million by 2032 registering a CAGR of 13.4% during the forecast period. Lung Disease Therapeutics Market Share : The global lung disease therapeutics market garnered a market value of US$ 79,833.6 Million in 2022 and is expected to accumulate a market value of US$ 145,960.2 Million by registering a CAGR of 6.21% in the forecast period 2022-2032. Catheter-Directed Thrombolysis Market Overview : The global catheter-directed thrombolysis market is valued at US$ 432.0 Million in 2022. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 814.0 Million by 2032. Staphylococcus Aureus Testing Market Demand : The staphylococcus aureus testing market is likely to cross the estimated market value of US$ 6.66 Billion by 2032, while it thrives in the global market at a lower CAGR of 4.9% (2022-2032). The market holds a revenue of US$ 3.94 Billion in 2022. COPD Therapeutics Market Growth : The global COPD therapeutics market garnered a market value of US$ 11,668.8 Million in 2022 and is expected to accumulate a market value of US$ 20,127.7 Million by 2032, registering a CAGR of 5.1% over the forecast period. About Future Market Insights (FMI) Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us: